City to sue Merck, Schering-Plough

The city of New Haven, Connecticut will be suing Merck and Schering-Plough on the basis that Vyotrin doesn't work.

New Haven, which has spent $100,000 shy of a half million dollars on Vytorin and Zetia for employees, will seek reimbursement for the tax money it spent on the medications.   

While Merck did not comment, a Schering-Plough spokesperson said the company stood behind its product and would fight any challenge vigorously. 

- check out the Pharmalot blog entry 

Suggested Articles

Pfizer has scored FDA approval for its Humira biosimilar, but it can't launch the product for several years under a patent settlement.

The 3-2 vote on the deal was split along the party lines, spelling trouble for future biopharma M&A deals should Democrats move into the White House.

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.